UnitedHealth Group Inc. (UNH) Stock Rating Lowered by Vetr Inc.
UnitedHealth Group Inc. (NYSE:UNH) was downgraded by research analysts at Vetr from a “buy” rating to a “hold” rating in a report released on Tuesday. They currently have a $144.66 target price on the healthcare conglomerate’s stock. Vetr‘s price objective points to a potential upside of 0.89% from the stock’s previous close.
Other research analysts have also issued research reports about the stock. Jefferies Group reiterated a “buy” rating and issued a $163.00 price objective on shares of UnitedHealth Group in a report on Sunday. Evercore ISI began coverage on shares of UnitedHealth Group in a report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 price objective for the company. Cowen and Company set a $150.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, September 6th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $178.00 price objective on shares of UnitedHealth Group in a report on Tuesday, September 6th. Finally, Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Two research analysts have rated the stock with a hold rating, twenty-four have issued a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $154.95.
Shares of UnitedHealth Group (NYSE:UNH) traded up 6.90% on Tuesday, reaching $143.39. 10,141,914 shares of the company’s stock were exchanged. UnitedHealth Group has a 52-week low of $107.51 and a 52-week high of $144.48. The stock has a market cap of $136.56 billion, a P/E ratio of 22.44 and a beta of 0.57. The company’s 50 day moving average price is $137.12 and its 200-day moving average price is $136.75.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/unitedhealth-group-inc-unh-stock-rating-lowered-by-vetr-inc.html
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The firm earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.77 earnings per share. Equities analysts forecast that UnitedHealth Group will post $7.90 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s payout ratio is currently 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.65% of the stock is owned by insiders.
Several hedge funds have recently made changes to their positions in UNH. Hanson McClain Inc. boosted its stake in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares in the last quarter. Harfst & Associates Inc. boosted its stake in UnitedHealth Group by 0.3% in the second quarter. Harfst & Associates Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $418,000 after buying an additional 8 shares in the last quarter. Kanaly Trust Co boosted its stake in UnitedHealth Group by 0.6% in the second quarter. Kanaly Trust Co now owns 1,772 shares of the healthcare conglomerate’s stock worth $250,000 after buying an additional 11 shares in the last quarter. Burke & Herbert Bank & Trust Co. boosted its stake in UnitedHealth Group by 0.4% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,877 shares of the healthcare conglomerate’s stock worth $403,000 after buying an additional 12 shares in the last quarter. Finally, First Financial Bank N.A. Trust Division boosted its stake in UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock worth $1,108,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 85.80% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.